Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to Treat Depression in People Living With HIV
NCT07007221Phase 2Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jul 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in major depressive disorder (MDD), sponsored by University of Minnesota. Planned start Jul 2026; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07007221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007221.